Global Hemostatic Agents Market

Hemostatic Agents Market Size, Share, Growth Analysis, By Type(Hemostats (Mechanical, Gelatin, Collagen, Oxidized regenerated cellulose)), By Application(Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery), By End User(Hospitals, Surgery Centers, Nursing Homes, and Others), By Region - Industry Forecast 2026-2033

Report ID: SQMIG35B2068 | Region: Global | Published Date: December, 2025
Pages: 242 |Tables: 127 |Figures: 81

To request a free sample copy of this report, please complete the form below.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt

    • FAQs

    Global Hemostatic Agents Market size was valued at USD 8.03 Billion in 2024 and is poised to grow from USD 8.74 Billion in 2025 to USD 17.15 Billion by 2033, growing at a CAGR of 8.8% during the forecast period (2026–2033). 

    Global Hemostatic Agents Market is fragmented and highly competitive. Key industry players are focused on product developments, new product launches, and geographical expansions to gain a significant amount of market share. 'Johnson & Johnson (USA) ', 'Pfizer Inc. (USA) ', 'Baxter International Inc. (USA) ', 'Becton, Dickinson and Company (USA) ', 'Medtronic plc (Ireland) ', 'Stryker Corporation (USA) ', 'Sanofi S.A. (France) ', 'CSL Limited (Australia) ', 'Zimmer Biomet Holdings, Inc. (USA) ', 'Teleflex Incorporated (USA) ', 'CryoLife, Inc. (USA) ', 'Integra LifeSciences Holdings Corporation (USA) ', 'Mallinckrodt Pharmaceuticals (UK) ', 'B. Braun Melsungen AG (Germany) ', 'Terumo Corporation (Japan) ', 'Smith & Nephew plc (UK) ', 'Haemonetics Corporation (USA) ', 'Ethicon, Inc. (USA) ', 'The Medicines Company (USA) ', 'Anika Therapeutics, Inc. (USA) '

    The spike in the number of surgical procedures performed globally has provided the impetus to offer a major boost to the rising incidence of bleeding issues during surgeries, which is the most crucial driving force of the global market. In the contemporary scenario, there is a wide range of medical devices available for care, as well as a considerable advance in the attainment of hemostasis in surgical procedures. According to recent estimates provided by the National Center for Biotechnology Information (NCBI), around 60-70% of all transfused red blood cells are used in a surgical context, as bleeding during surgery is one of the most feared problems that might occur during these procedures. This has resulted in a significant demand for the product offerings in the global market, as many surgeons prefer to use these goods in surgical operations with a low risk of bleeding issues.

    The leading cause of military and civilian mortality is hemorrhage. The uncontrolled hemorrhage causes more than 30% of traumatic deaths in emergency conditions, and excessive bleeding is the leading cause of military casualties. Hemostatic drugs have been shown to be useful in hospitals and to save lives in high-stress situations. This will drive the hemostats market forward. The agents save lives by preventing hypothermia, infections, multiple organ failure, and acidosis. It is a critical stage in trauma treatment.

    North America dominated the global hemostatic agent market. Some of the elements contributing to the dominance include the use of technologically sophisticated products and rising surgical operation numbers, which result in increased demand for the product.

    Related Reports

    Hemostasis Products Market
    Buy Now GET FREE SAMPLE
    Hemostasis and Tissue Sealing Agents Market
    Buy Now GET FREE SAMPLE
    Hemophilia Treatment Market
    Buy Now GET FREE SAMPLE
    Hemorrhoid Treatment Devices Market
    Buy Now GET FREE SAMPLE
    Hemp Market
    Buy Now GET FREE SAMPLE
    Hemophilia Market
    Buy Now GET FREE SAMPLE
    Hemoglobinopathies Treatment Market
    Buy Now GET FREE SAMPLE
    Coagulant Market
    Buy Now GET FREE SAMPLE

    Feedback From Our Clients

    Global Hemostatic Agents Market

    Report ID: SQMIG35B2068

    $5,300
    BUY NOW